<SEC-DOCUMENT>0001179110-14-009835-index.html : 20140624 <SEC-HEADER>0001179110-14-009835.hdr.sgml : 20140624 <ACCEPTANCE-DATETIME>20140605162039 ACCESSION NUMBER: 0001179110-14-009835 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140604 FILED AS OF DATE: 20140605 DATE AS OF CHANGE: 20140605 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Celldex Therapeutics, Inc. CENTRAL INDEX KEY: 0000744218 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 133191702 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 119 FOURTH AVE CITY: NEEDHAM STATE: MA ZIP: 02494 BUSINESS PHONE: 7814330771 MAIL ADDRESS: STREET 1: 119 FOURTH AVE CITY: NEEDHAM STATE: MA ZIP: 02494-2725 FORMER COMPANY: FORMER CONFORMED NAME: AVANT IMMUNOTHERAPEUTICS INC DATE OF NAME CHANGE: 19980828 FORMER COMPANY: FORMER CONFORMED NAME: T CELL SCIENCES INC DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Davis Thomas Andrew CENTRAL INDEX KEY: 0001338185 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15006 FILM NUMBER: 14893918 MAIL ADDRESS: STREET 1: 65 WEST WATKINS MILL ROAD CITY: GAITHERSBURG STATE: MD ZIP: 20878 </SEC-HEADER> <DOCUMENT> <TYPE>4 <SEQUENCE>1 <FILENAME>edgar.xml <DESCRIPTION>FORM 4 - <TEXT> Document 1 - file: edgar.html
Document 1 - RAW XML: edgar.xml
</DOCUMENT> </SEC-DOCUMENT>